Influence of mutation in human apolipoprotein A-1 gene promoter on plasma LDL cholesterol response to dietary fat

[1]  J. Huttunen,et al.  Apolipoprotein E polymorphism influences the serum cholesterol response to dietary intervention. , 1991, Metabolism: clinical and experimental.

[2]  N. Miller,et al.  Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism. , 1989, Arteriosclerosis.

[3]  P. Talmud,et al.  Xbal polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention , 1990, Clinical genetics.

[4]  D. Jacobs,et al.  Variability in Individual Serum Cholesterol Response to Change in Diet , 1983, Arteriosclerosis.

[5]  N. Tuteja,et al.  Transcription efficiency of human apolipoprotein A‐I promoter varies with naturally occurring A to G transition , 1992, FEBS letters.

[6]  C. Fielding,et al.  A protein cofactor of lecithin:cholesterol acyltransferase. , 1972, Biochemical and biophysical research communications.

[7]  A. Kessling,et al.  G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations. , 1990, Molecular biology & medicine.

[8]  J. Breslow,et al.  Polymorphism in the human apolipoprotein A-I gene promoter region. Association of the minor allele with decreased production rate in vivo and promoter activity in vitro. , 1992, The Journal of clinical investigation.

[9]  A. Keys,et al.  Prediction of serum-cholesterol responses of man to changes in fats in the diet. , 1957, Lancet.

[10]  M. Farrall,et al.  Familial combined hyperlipidaemia linked to the apolipoprotein AI–CIII–AIV gene cluster on chromosome 11q23q–q24 , 1991, Nature.

[11]  D. Hegsted,et al.  Quantitative effects of dietary fat on serum cholesterol in man. , 1965, The American journal of clinical nutrition.

[12]  S. Humphries,et al.  Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. , 1993, Atherosclerosis.

[13]  R. Krauss,et al.  Modification of LCAT activity and HDL structure. New links between cigarette smoke and coronary heart disease risk. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[14]  F. Baralle,et al.  Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia. , 1990, Journal of lipid research.

[15]  T. Read,et al.  Cigarette smoke alters chylomicron metabolism in rats. , 1993, Journal of vascular surgery.

[16]  P. Monaci,et al.  Promoter elements and factors involved in hepatic transcription of the human ApoA-I gene positive and negative regulators bind to overlapping sites. , 1991, The Journal of biological chemistry.

[17]  A. von Eckardstein,et al.  Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. , 1992, American journal of human genetics.

[18]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[19]  V. Gudnason,et al.  Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[20]  E. Boerwinkle,et al.  Genetic variation at the apolipoprotein gene loci contribute to response of plasma lipids to dietary change , 1990, Genetic epidemiology.

[21]  J. Blangero,et al.  Genetic analysis of apolipoprotein A-I in two dietary environments. , 1990, American journal of human genetics.